Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study on the Treatment Strategy of Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy

NCT05156021 is registered in ClinicalTrials.gov with Ruijin Hospital as lead sponsor.

NCT NCT05156021
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05156021 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study on the Treatment Strategy of Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy
Lead sponsor
Ruijin Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2021
Completion date
December 31, 2022
Enrollment
39 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

neovascular glaucoma, proliferative diabetic retinopathy